Albright like syndrome

Revision as of 17:25, 1 August 2012 by Prashanthsaddala (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Albright like syndrome

Articles

Most recent articles on Albright like syndrome

Most cited articles on Albright like syndrome

Review articles on Albright like syndrome

Articles on Albright like syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Albright like syndrome

Images of Albright like syndrome

Photos of Albright like syndrome

Podcasts & MP3s on Albright like syndrome

Videos on Albright like syndrome

Evidence Based Medicine

Cochrane Collaboration on Albright like syndrome

Bandolier on Albright like syndrome

TRIP on Albright like syndrome

Clinical Trials

Ongoing Trials on Albright like syndrome at Clinical Trials.gov

Trial results on Albright like syndrome

Clinical Trials on Albright like syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Albright like syndrome

NICE Guidance on Albright like syndrome

NHS PRODIGY Guidance

FDA on Albright like syndrome

CDC on Albright like syndrome

Books

Books on Albright like syndrome

News

Albright like syndrome in the news

Be alerted to news on Albright like syndrome

News trends on Albright like syndrome

Commentary

Blogs on Albright like syndrome

Definitions

Definitions of Albright like syndrome

Patient Resources / Community

Patient resources on Albright like syndrome

Discussion groups on Albright like syndrome

Patient Handouts on Albright like syndrome

Directions to Hospitals Treating Albright like syndrome

Risk calculators and risk factors for Albright like syndrome

Healthcare Provider Resources

Symptoms of Albright like syndrome

Causes & Risk Factors for Albright like syndrome

Diagnostic studies for Albright like syndrome

Treatment of Albright like syndrome

Continuing Medical Education (CME)

CME Programs on Albright like syndrome

International

Albright like syndrome en Espanol

Albright like syndrome en Francais

Business

Albright like syndrome in the Marketplace

Patents on Albright like syndrome

Experimental / Informatics

List of terms related to Albright like syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S

Synonyms and keywords: 2q37 microdeletion syndrome; Albright hereditary osteodystrophy 3; Albright hereditary osteodystrophy-like syndrome; brachydactyly-intellectual deficit; monosomy 2q37-qter

Overview

2q37 microdeletion syndrome is a chromosomal anomaly involving deletion of chromosome band 2q37 and manifests as three major clinical findings: developmental delay, skeletal malformations and facial dysmorphism.[1]

Pathophysiology

Genetics

The monosomy can be pure or can be associated with additional chromosomal imbalances.

The deletion involves the terminal region of chromosome 2 with breakpoints at or within band 2q37. Band 2q37 contains three sub-bands with over 80 genes being located in the 2q37.1-q37.3 region.

A few genotype-phenotype correlations have been identified including a critical region for the Albright hereditary osteodystrophy(AHO)-like phenotype and candidate genes for brachymetaphalangism, obesity and the autistic behavioral spectrum.

Associated Conditions

  • Major malformations occur in 30% of patients with 2q37 deletions. Congenital heart, gastrointestinal (30% of patients), genitourinary (11% of cases) and central nervous system malformations (6% of patients) have been reported.
  • Hypotonia is often present.
  • Seizures are described in 35% of patients and behavioral anomalies are reported in about 30% of cases.
  • Repetitive behavior and severe communication and social interaction deficits, stereotypic movements, intermittent aggressivity, hyperactivity, attention deficit disorder, obsessive-compulsive disorder and sleep disturbances are the characteristic features of a distinct subtype of autism associated with the 2q37 deletion.

Differentiating 2q37 microdeletion syndrome from other Diseases

The differential diagnosis should include other segmental aneusomy syndromes and Prader-Willi syndrome (see this term). AHO (pseudohypoparathyroidism; PHP) and pseudo-PHP (PPHP; see these terms) should also be included in the differential diagnosis but calcium, phosphorus, and parathormone levels are in the normal range in patients with deletion 2q37.

Epidemiology and Demographics

Incidence is estimated at less than 1 in 10,000 and more than 100 individuals have been reported.

Screening

Screening for a translocation should also be conducted as the deletion may be the result of the transmission of a derivative chromosome.

Natural History, Complications, and Prognosis

The prognosis depends on the malformations (cardiac, cerebral or intestinal) associated with the 2q37 deletion.

Diagnosis

Symptoms

Most of the initially reported patients had an Albright hereditary osteodystrophy-like phenotype (referred to as AHO3) with developmental delay or intellectual deficit, short stature (23% of patients), a tendency toward obesity with age, and brachymetaphalangism (50% of patients).

Physical Examination

Appearance of the Patient

Skin

Head

Eyes

Nose

Throat

Chest

Nipples are often widely set, distally placed or supernumerary.

Extremities

Laboratory Findings

Biomarker Studies

Diagnosis relies on cytogenetic analysis and molecular characterization.

Treatment

Management of deletion 2q37 patients should be multidisciplinary and include a comprehensive evaluation of the major clinical criteria.

Speech, physical and occupational therapy are required.

Genetic Counseling

Antenatal diagnosis is feasible and genetic counseling should be proposed.

References


Template:WikiDoc Sources